Our purpose and values
We founded Kalium Health with the aim of providing real-world electrolyte data to transform the management of cardiorenal diseases.
We have a world-class team, led by science and dedicated to medical product development. Our clinical focus is on kidney disease, heart disease and related chronic conditions where the cost of care is disproportionately high and the opportunity to improve health outcomes for a large population is great.
The way we choose to operate as a company, and behave as a team, is based upon our values:
Care: Patients are at the heart of everything we do
Creativity: We encourage new ideas and ways of thinking
Integrity: We are fair, honest and considerate
Respect: We respect individual differences
Teamwork: We listen and we encourage collaboration
Our story began with patients
We founded Kalium Health because we believe that people living with chronic diseases should be able to enjoy a life free of worry and risk.
It was patients at the clinic of our Chief Medical Officer Professor Karet who helped to spark the idea of our first product: a device that would allow them to monitor their own blood potassium concentration wherever and whenever it suited them.
While patients so clearly wanted to be able to better manage their health between hospital visits, we saw the huge potential that accurate health monitoring at home has to improve care delivery and optimise treatments and health outcomes.
“Our innovation will enable us as clinicians to better manage patients; and enable patients to better manage themselves”
Prof Fiona Karet FRCP FMedSci
Chief Medical Officer
World-class clinical and technical innovation
To turn our ideas into reality we follow a multi-disciplinary approach. We combine clinical expertise in nephrology with micro-electronic chemical sensing and medical device engineering to generate technology and products that have high performance at a low cost, while remaining scalable and suitable for widespread adoption.
We have formed strategic partnerships with patient organisations (including Kidney Research UK), investors (including Cambridge Enterprise, Martlet Capital and Cambridge Angels) and funding bodies (including the National Institute for Health Research) to support us as we bring our innovation to healthcare systems around the world.
A responsible and sustainable approach
We hold very high standards when it comes to collaborating with colleagues and external organisations, our approach to doing business and our impact upon society. You can read our Environmental, Social and Governance (ESG) policy here.
Our work supports the following United Nations Sustainable Development Goals: